Brand names: Eucrisa
12.1 Mechanism of Action Crisaborole is a phosphodiesterase 4 (PDE-4) inhibitor. PDE-4 inhibition results in increased intracellular cyclic adenosine monophosphate (cAMP) levels. The specific mechanism(s) by which crisaborole exerts its therapeutic action for the treatment of atopic dermatitis is not well defined.
4 documented side effects by frequency
No community discussions found for CRISABOROLE yet.
Every figure on this page links back to its primary source. See data sources for full provenance.
14 available comparisons
Dosage Forms
Tablet
Route
Topical